Frazier Life Sciences Management, L.P. Edgewise Therapeutics, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.67 Billion
- Q4 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 1,271,245 shares of EWTX stock, worth $31.1 Million. This represents 2.04% of its overall portfolio holdings.
Number of Shares
1,271,245
Previous 2,832,867
55.13%
Holding current value
$31.1 Million
Previous $75.6 Million
55.11%
% of portfolio
2.04%
Previous 4.07%
Shares
8 transactions
Others Institutions Holding EWTX
# of Institutions
216Shares Held
98.4MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$368 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$218 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$151 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$147 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$123 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.55B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...